Literature DB >> 9184316

6p24-22 region and major psychoses in the Eastern Quebec population. Le Groupe IREP.

M Maziade1, L Bissonnette, E Rouillard, M Martinez, M Turgeon, L Charron, V Pouliot, P Boutin, D Cliche, C Dion, J P Fournier, Y Garneau, J C Lavallée, N Montgrain, L Nicole, A Pirès, A M Ponton, A Potvin, H Wallot, M A Roy, C Mérette.   

Abstract

Recent reports of a linkage trend in 6p24-22 for schizophrenia (SZ), in different samples, were tempered by the concurrent evidence of negative reports in other samples. In the studies showing positive results, different definitions of affection and a wide spectrum of diagnoses were used. Our objectives were not only to test for linkage at 6p24-22 in the Eastern Quebec population, but also to test whether this putative vulnerability locus was either selectively linked to schizophrenia (SZ), or to bipolar disorder (BP), or to both major psychoses. Parametric and nonparametric linkage analyses with 12 microsatellite markers in 6p24-p22 were performed on a sample of 18 large multigenerational pedigrees (N = 354) either affected by SZ, or by BP, or equally affected by both major psychoses (i.e., mixed pedigrees). Three affection definitions were usually tested in our program: one on schizophrenia (SZ), one on bipolar disorder (BP), and one that comprised SZ and BP under the hypothesis of a susceptibility locus common to both in major psychoses (common locus, CL). The results of parametric analyses did not support a major gene hypothesis. However, in one large mixed pedigree (#151), we observed with the common locus phenotype (CL) lod scores of 2.49 and 2.15, respectively, at the D6S296 and D6S277 loci under a dominant model. Our data suggest the presence of a potential vulnerability locus at 6p24-22 that could be related to both schizophrenia and bipolar affective disorder. These results may be seen as congruent with former studies that used schizoaffective as well as schizophrenia diagnoses as entry criteria for the affected families, and used an affection definition that comprised affective psychoses as well as schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9184316

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Replication of linkage studies of complex traits: an examination of variation in location estimates.

Authors:  S B Roberts; C J MacLean; M C Neale; L J Eaves; K S Kendler
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  The genetics of schizophrenia.

Authors:  M T Tsuang; W S Stone; S V Faraone
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

3.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23.

Authors:  H M Gurling; G Kalsi; J Brynjolfson; T Sigmundsson; R Sherrington; B S Mankoo; T Read; P Murphy; E Blaveri; A McQuillin; H Petursson; D Curtis
Journal:  Am J Hum Genet       Date:  2001-03       Impact factor: 11.025

Review 4.  Linkage studies of schizophrenia.

Authors:  Brien Riley
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Significant linkage for Tourette syndrome in a large French Canadian family.

Authors:  C Mérette; A Brassard; A Potvin; H Bouvier; F Rousseau; C Emond; L Bissonnette; M A Roy; M Maziade; J Ott; C Caron
Journal:  Am J Hum Genet       Date:  2000-09-11       Impact factor: 11.025

6.  Association study of DTNBP1 with schizophrenia in a US sample.

Authors:  Lingjun Zuo; Xingguang Luo; Henry R Kranzler; Lingeng Lu; Robert A Rosenheck; Joyce Cramer; Daniel P van Kammen; Joseph Erdos; Dennis S Charney; John Krystal; Joel Gelernter
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

7.  Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.

Authors:  V Saviouk; E W C Chow; A S Bassett; L M Brzustowicz
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

8.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.

Authors:  Richard E Straub; Yuxin Jiang; Charles J MacLean; Yunlong Ma; Bradley T Webb; Maxim V Myakishev; Carole Harris-Kerr; Brandon Wormley; Hannah Sadek; Bharat Kadambi; Anthony J Cesare; Avi Gibberman; Xu Wang; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Am J Hum Genet       Date:  2002-07-03       Impact factor: 11.025

Review 9.  Three independent lines of evidence suggest retinoids as causal to schizophrenia.

Authors:  A B Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction.

Authors:  Sharon S Lander; Usman Khan; Nicole Lewandowski; Darpan Chakraborty; Frank A Provenzano; Susana Mingote; Sergiy Chornyy; Francesca Frigerio; Pierre Maechler; Hanoch Kaphzan; Scott A Small; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.